| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/16/2004 | CA2415519A1 Systemic lupus erythematosus |
| 02/12/2004 | WO2004013632A1 Method for solution based diagnosis |
| 02/12/2004 | WO2004013630A1 Method for determination of thymidine kinase 1 activity and the use thereof |
| 02/12/2004 | WO2004013629A2 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 02/12/2004 | WO2004013628A1 Fluorescence polarization assay |
| 02/12/2004 | WO2004013620A1 Fluorescence correlation spectroscopy instrument |
| 02/12/2004 | WO2004013610A2 Method of measuring molecular interactions |
| 02/12/2004 | WO2004013609A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004013607A2 Methods, devices and kits for multiplex blotting of biological samples from multi-well plates |
| 02/12/2004 | WO2004013606A2 Species specific dna detection |
| 02/12/2004 | WO2004013604A2 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays |
| 02/12/2004 | WO2004013357A2 Nucleotide sequences specific to francisella tularensis and methods for the detection of francisella tularensis |
| 02/12/2004 | WO2004013354A1 Amplification of nucleic acids |
| 02/12/2004 | WO2004013352A1 Analysis of biological samples |
| 02/12/2004 | WO2004013351A2 Target dna |
| 02/12/2004 | WO2004013349A2 Method for examining and evaluating virus enzymes in high throughput screening (hts) |
| 02/12/2004 | WO2004013348A2 Method for determining endoglycosidase enzyme activity |
| 02/12/2004 | WO2004013347A2 Methods of identifying compounds that modulate protein activity |
| 02/12/2004 | WO2004013346A2 Methods and compositions for genotyping |
| 02/12/2004 | WO2004013334A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | WO2004013331A1 Pathogenic genes of xanthomonas oryzae pv. oryzae and utilization thereof |
| 02/12/2004 | WO2004013326A1 Cartilage differentiation inhibiting gene |
| 02/12/2004 | WO2004013324A1 Novel crystalline tryptase and utilization thereof |
| 02/12/2004 | WO2004013319A2 Regulation of human esterase |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013308A2 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | WO2004013305A2 Improved compositions for in vitro amplification of nucleic acids |
| 02/12/2004 | WO2004013291A2 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013284A2 A method to assess genomic dna methylation using high-performance liquid chromatography-electospray ionization mass spectrometry |
| 02/12/2004 | WO2004013277A2 Large circular sense molecule array |
| 02/12/2004 | WO2004013275A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/12/2004 | WO2004013274A2 Ghrelin binding nucleic acids |
| 02/12/2004 | WO2004013204A2 Polymer extraction methods |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | WO2004013152A2 Novel targets for lithium therapy |
| 02/12/2004 | WO2004013046A2 Method for locating hidden microorganism contaminated surfaces in industrial water systems |
| 02/12/2004 | WO2004012847A2 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 02/12/2004 | WO2004012757A2 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 02/12/2004 | WO2004012755A1 Methods for regulating brca1-brca2-containing complex activity |
| 02/12/2004 | WO2004012751A1 Bacterial cell wall skeleton component preparaion |
| 02/12/2004 | WO2004012683A2 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | WO2004012675A2 Lipid binding molecules and methods of use |
| 02/12/2004 | WO2004012668A2 Sodium channel alpha subunit variants |
| 02/12/2004 | WO2004012660A2 Mk2 interacting proteins |
| 02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
| 02/12/2004 | WO2004012588A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004012585A2 Electrophysiology assay methods |
| 02/12/2004 | WO2003104398A3 Allelic variation in human gene expression |
| 02/12/2004 | WO2003102238A3 Direct pcr quantification |
| 02/12/2004 | WO2003102232A3 Amplification of ribonucleic acids |
| 02/12/2004 | WO2003102222A3 Continuous-flow enzyme assay with mass spectrometry detection |
| 02/12/2004 | WO2003100019A3 Nested pcr employing degradable primers |
| 02/12/2004 | WO2003095673A3 Method for biochemical analysis of dna and arrangement associated therewith |
| 02/12/2004 | WO2003095608A3 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 02/12/2004 | WO2003089587A3 Method to enhance homologous recombination |
| 02/12/2004 | WO2003089456A3 Peptide inhibitors of protein kinase c |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003083053A3 Constructing very long dna sequences from synthetic dna molecules |
| 02/12/2004 | WO2003082901A3 Template-driven processes for synthesizing polymers and components related to such processes |
| 02/12/2004 | WO2003076657A3 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes |
| 02/12/2004 | WO2003076566A3 Enzymatic ligation-based identification of nucleotide sequences |
| 02/12/2004 | WO2003073823A3 PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2003070171A9 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 02/12/2004 | WO2003068923A9 Signal for packaging of influenza virus vectors |
| 02/12/2004 | WO2003068050A3 Method for the detecion of carcinoembryonic agent and cancer diagnosis method based thereon |
| 02/12/2004 | WO2003066212A3 Microarray synthesis instrument and method |
| 02/12/2004 | WO2003065979A3 Methods of diagnosis, monitoring and treatment of fertility |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003062467A3 Tissue rejection |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003054516A3 Devices and methods for isolating and detecting specific substances in complex matrices |
| 02/12/2004 | WO2003054234A9 Pcr based high throughput polypeptide screening |
| 02/12/2004 | WO2003052135A3 Method and nucleic acids for the analysis of a lung cell proliferative disorder |
| 02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
| 02/12/2004 | WO2003050250A3 Chondrocyte precursors derived from human embryonic stem cells |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003048727A3 Identification of rearrangements in nucleic acid molecules |
| 02/12/2004 | WO2003046203B1 Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003042408A3 Sequence variants of the human growth hormone gene and methods for detection |
| 02/12/2004 | WO2003040401A9 General screening method for ligand-protein interactions |
| 02/12/2004 | WO2003039404A3 Methods for treating ocular neovascular diseases |
| 02/12/2004 | WO2003038726A3 A method for epigenetic knowledge generation |
| 02/12/2004 | WO2003038130A3 Therapeutics and diagnostics for disorders of erythropoiesis |
| 02/12/2004 | WO2003036299A3 Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope |
| 02/12/2004 | WO2003035907A3 Method and means for early identification of cardiac decompensation risks |
| 02/12/2004 | WO2003035905A3 Method for determining bacteriostatic or bactericidal activity of antibiotic agents by quantitative pcr |
| 02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003031650A3 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 02/12/2004 | WO2003027238A3 Stabilization of t4 endonuclease v |
| 02/12/2004 | WO2003025219A3 Method for sequencing nucleic acids |
| 02/12/2004 | WO2003025202A3 Engineered templates and their use in single primer amplification |
| 02/12/2004 | WO2003023056A3 Specific markers for multiple sclerosis |
| 02/12/2004 | WO2003021220A3 Assays for inositol phosphates |
| 02/12/2004 | WO2003018769A3 Amplified gene involved in cancer |
| 02/12/2004 | WO2003014698A3 Biological assay detection method |
| 02/12/2004 | WO2003014382B1 Device for analyzing nucleic acid |